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Background. Exposure and response prevention (ERP) is an effective treatment for 
obsessive-compulsive disorder (OCD), but it is unclear how symptom reduction is related to 
changes in the brain. We aimed to determine the effects of a 4-day concentrated ERP program 
(Bergen 4-Day Treatment, B4DT) on the static and dynamic functional connectome in OCD 
patients.  
Methods. Thirty-four OCD patients (25 unmedicated) underwent resting-state functional 
magnetic resonance imaging the day before the B4DT, and 28 (21 unmedicated) were 
rescanned after one week. Twenty-eight healthy controls were also scanned for baseline 
comparisons and 19 were rescanned after one week. Static and dynamic graph measures were 
quantified to determine network topology at the global, subnetwork, and regional level 
(including efficiency, clustering, between-subnetwork connectivity, and node flexibility in 
module allegiance). The Yale-Brown Obsessive Compulsive Scale was used to measure 
symptom severity.  
Results. Twenty-four (86%) patients responded to treatment. We found significant group × 
time effects in frontoparietal-limbic connectivity (ηp2=0.19, p=.03) and flexibility of the right 
subgenual anterior cingulate cortex (ηp2=0.18, p=.03) where, in both cases, unmedicated 
patients showed significant decreases while healthy controls showed no significant changes. 
Healthy controls showed increases in global and subnetwork efficiency and clustering 
coefficient, particularly in the somatomotor subnetwork.  
Conclusions. Concentrated ERP, in unmedicated OCD patients, leads to decreased 
connectivity between the frontoparietal and limbic subnetworks and less flexibility of the 
connectivity of the sgACC, suggesting a more independent and stable network topology. This 
may represent less limbic interference on cognitive control subnetworks after treatment. 
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Obsessive-compulsive disorder (OCD) is characterized by recurrent and distressing 
obsessions and repetitive physical or mental compulsions (1). OCD is often highly 
debilitating (2) and remains chronic if adequate treatment is not provided (3). Exposure and 
response prevention (ERP) is an effective treatment, but a subset of patients do not benefit 
from standard ERP (4, 5). 
OCD has been related to abnormal function, structure and connectivity of cortico-
striato-thalamo-cortical (CSTC), fronto-limbic and fronto-parietal circuits (6-10). Graph 
theory has increasingly been used to study abnormal brain connectivity and topology in OCD 
from a network perspective (11-18), and describes the properties of the brain network or 
“connectome” (19). Previous studies have reported conflicting findings, with some reporting 
that the connectome of OCD patients showed less small-worldness, indicating that the brain 
of OCD patients is less well-interconnected (14, 20, 21). Some also found that OCD patients 
showed less differentiated modules (clusters of highly interconnected nodes) compared with 
healthy controls, as well as altered connectivity between them (16, 21). Recent technical 
advances have also made it possible to study time-evolving dynamic connectivity patterns of 
the functional connectome (22), but has so far not been used in the study of OCD or treatment 
effects. 
 Treatment studies measuring changes in static graph measures after ERP in OCD 
patients have found an increase in global clustering coefficient (23), increased connectivity 
between frontal, striatal, parietal, and cerebellar regions (24), as well as fewer connections 
between the dorsolateral prefrontal cortex and the rest of the brain (25). However, previous 
findings are often limited by high rates of concurrent psychotropic medication (12, 23), where 
none have investigated dynamic connectivity or used intensive treatment to investigate rapid 
changes in the connectome. Methodological heterogeneity (e.g. motion correction, global 
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signal regression, and definition of nodes) has likely also contributed to inconsistencies across 
studies (26, 27). 
The Bergen 4-day treatment (B4DT) is delivered during four consecutive days, where 
the two middle days are allocated to therapist-assisted ERP, followed by three weeks of self-
administered ERP. The B4DT has shown to be highly effective for OCD patients with 
remission rates of about 75% one week after treatment (28, 29), and stable improvements 
after four years (30, 31). Given the treatment’s rapid effect on OCD symptoms and very high 
rate of remission, it provides an ideal context to look at brain changes associated with 
symptom reduction. 
In the present study, we investigated pre-to-post-treatment changes in the static and 
dynamic functional connectome in OCD patients, and compared patients the day before 
treatment and one week later (three days after the B4DT) with healthy controls that were also 
scanned twice. Following a preregistered analysis plan with hypotheses (see 
https://osf.io/bxmh4/), we investigated graph measures at the global, subnetwork, and regional 
levels. Based on previous studies of global, subnetwork and regional connectivity in OCD, we 
hypothesized that before treatment OCD patients would show less efficiency and clustering at 
the global level (14), within the default mode (DMN), ventral attention (VAN), frontoparietal 
(FPN) and somatomotor (SMN) subnetworks (32), greater efficiency and clustering in the 
limbic subnetwork (8), and higher connectivity between subnetworks relative to healthy 
controls (32). We also expected OCD patients to show higher node strength, clustering, and 
betweenness centrality in the bilateral subgenual anterior cingulate cortex (sgACC), 
amygdala, dorsolateral and ventromedial putamen, and caudate nucleus, which have 
previously been implicated in OCD (11, 13-15, 17). We further hypothesized that the 
treatment would normalize these abnormalities in OCD patients (see Supplemental Table 2 
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for all analyses). We used an exploratory approach when investigating the dynamic graph 
measures, as these have not been previously assessed in OCD. 
Methods 
Participants 
Thirty-five OCD patients were recruited from a specialized outpatient OCD clinic at 
Haukeland University Hospital, Bergen, Norway. Thirty-one healthy controls were recruited 
through bulletin boards, social media, and emails to local businesses. Patients were recruited 
if they were 18 years or older, had a primary diagnosis of OCD, a minimum Y-BOCS score of 
16, and were fluent in Norwegian. Exclusion criteria for OCD patients were symptoms 
primarily associated with hoarding, ongoing substance abuse, lifetime bipolar disorder or 
psychosis, suicidal ideation, intellectual disability based on previous medical history, 
unwilling to refrain from anxiety reducing substances such as benzodiazepines) or  alcohol 
during the two days of exposure. No participants could have pacemakers or other 
contraindications for MRI, epilepsy or pregnancy. After initial data processing the baseline 
sample consisted of 34 OCD patients (nine used psychotropic medication; seven serotonin re-
uptake inhibitors (SRI) only, one SRI plus an antipsychotic drug, one methylphenidate) and 
28 healthy controls. Twenty-eight OCD patients (six used SRI only and one used 
methylphenidate) and 19 healthy controls were included for longitudinal analyses (See 
Supplemental Figure 1 for flow diagram). The study was approved by the Regional Ethics 
Committee for South-Eastern Norway and all participants provided informed written consent 
in accordance with the Declaration of Helsinki. 
 
Treatment 
The Bergen 4-Day Treatment (B4DT) is an individually tailored and therapist-assisted 
exposure-based treatment format delivered during four consecutive days. Effectiveness 
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studies of both adult and adolescent OCD patients (29, 33) have shown that around 90% of 
the patients respond and 75% remit one week after treatment. The improvements in symptom 
severity are durable between three months to four years of follow-up (30, 31), and have been 
replicated in independent samples of patients and therapists (28, 34), new clinics (35), a 
randomized controlled trial (36), and is currently being implemented in Sweden, Iceland, and 
the United States. The B4DT is delivered in a group setting of three to six patients with a 1:1 
ratio between patients and therapists. The first day consists of a three-hour group session with 
psychoeducation and planning of individual exposure tasks. The next two days consist of 
eight to ten hours of therapist-assisted exposure in a wide range of relevant settings, including 
in patients’ home, work, or local area. Individualized exposures are intermixed with meetings 
between all patients and therapists. Patients are also instructed to perform exposure as 
homework between the second and fourth day. The last day consists a three-hour session 
focused on summarizing the treatment, relapse prevention, and planning self-exposure for the 
next three weeks. A core principle of B4DT is the “Lean into the anxiety” (LET) technique 
where patients are taught to actively seek out anxiety-provoking situations without regulating 
their emotions by performing compulsions, safety behaviors, or subtle avoidance. Instead, 
patients are instructed to use both planned exposure tasks and spontaneous opportunities to do 
something that is incompatible with having the disorder, e.g. increase feelings of uncertainty. 
Therapists act as coaches to support the patient and facilitate relevant exposure tasks while 
gradually leaving the responsibility to the patient. Therapists work together as a team, and can 
flexibly reallocate therapists to provide struggling patients with the most experienced 
therapists (see Kvale, Hansen (35) for more information). 
 
Clinical Assessments 
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The Structured Clinical Interview for DSM-IV (SCID) (37) was used to diagnose current and 
lifetime mental health disorders in OCD patients and to rule out any current or lifetime 
disorders in healthy controls. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) (38) 
was used as the primary measure of symptom severity in OCD patients. Both the SCID and 
Y-BOCS were performed by a trained clinical psychologist, and patients were assessed by an 
external rater that was not part of the treatment. Clinically significant change was calculated 
based on international consensus criteria for the Y-BOCS (39), where response required a 
minimum of 35% improvement and remission required a total score under 13. All participants 
also completed the Obsessive Compulsive Inventory Revised (OCI-R) (40), Patient Health 
Questionnaire 9 (PHQ-9) (41) and Generalized Anxiety Disorder 7 (GAD-7) (42) for 
symptoms of OCD, depression and anxiety, respectively. 
 
MRI acquisition, preprocessing and construction of connectivity matrices 
Scanning was performed on a 3T General Electric Discovery MR750 (GE Healthcare, 
Milwaukee, Wisconsin, USA) using an eight-channel head coil. A T1-weighted image was 
acquired using a 256x256 matrix, 192 slices, voxel size= 1x1x1mm, TE=3ms, TR=7s, flip 
angle=12°, FoV=256mm. Resting state functional magnetic resonance imaging (fMRI; not 
including most of the cerebellum) was acquired using 160 echo-planar images (EPI; 64x64 
matrix, 34 slices, slice thickness=3mm (gap=0.3mm), TE=30ms, TR=1.8s, FoV=220mm, flip 
angle=80°, voxel size=3.44x3.44x3.3mm, interleaved slice acquisition). Four dummy 
volumes were acquired and automatically discarded to reach steady-state magnetization. 
Participants were instructed to lie still with closed eyes and not fall asleep. 
Participants were excluded if they showed movement exceeding a mean relative root 
mean square (RMS) displacement of 0.2mm or more than 20 volumes with RMS above 
0.25mm (26). FMRIB’s Software Library version 5.0.10 (FSL) (43) was used to preprocess 
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the fMRI data. Briefly, EPI volumes were motion corrected (using 6 regressors and ICA-
AROMA) (44), smoothed (5mm kernel), nuisance signals in white matter and cerebrospinal 
fluid were removed using linear regression, and the volumes were then high-pass filtered 
(100s cut-off). Global signal regression was not used due to its controversial effects on the 
connectivity between nodes (27). EPIs were registered to the T1-weighted image and 
subsequently parcellated into 226 nodes. Two–hundred-and-ten cortical, as well as four 
bilateral dorsolateral and ventromedial putamen nodes, were defined based on the 
Brainnetome Atlas (45). The bilateral thalamus, caudate nucleus, pallidum, hippocampus, 
amygdala, and nucleus accumbens were individually segmented using FSL FIRST (46). FSL 
was also used to calculate voxels with signal intensities in the lowest quartile and nodes with 
less than four voxels with adequate signal, where then discarded to ensure the robustness of 
nodal connections. This resulted in 200 nodes with adequate signal across all participants (see 
Supplemental Table 2 for a complete list). Time-series were then extracted from each node, 
and we used Morlet wavelet coherence (47) to calculate the coherence between each pair of 
nodes to construct a weighted connectivity matrix per subject and time point. We chose the 
frequency range between 0.06 to 0.125Hz as connections in this range has been suggested as 
most reliable, robust to artifacts, and sensitive to neuropsychiatric disorders (20, 48). The 
resulting fully weighted connectivity matrices were not thresholded in order to maximize the 
contained information and to avoid arbitrary sparsity levels (49, 50), and were used to 
calculate static network measures using in-house scripts and the Brain Connectivity Toolbox 
(version 2017-15-01)(19). For dynamic measures we used 136 sliding windows to assess 
variation during scanning (window size=25 TRs, each window was shifted 1 TR) (51), and 
dynamic measures were then calculated (22). Analyses were performed in MATLAB R2017a 
(MathWorks, Inc, Natick, MA, USA). We assigned all nodes to the visual, dorsal attention 
(DAN), limbic, SMN, VAN, FPN, or DMN subnetworks (See Supplemental Table 2) based 
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on the atlas by Yeo and colleagues (52-54). Between-subnetwork connectivity was tested by 
averaging the connectivity between the nodes of each subnetwork pair. 
 
Graph measures 
Based on previous studies of OCD we calculated efficiency, clustering coefficient, 
modularity, strength, and betweenness centrality as static graph measures. For dynamic 
measures we used flexibility (switches in module allegiance), promiscuity (switches in 
allegiance between multiple modules), temporal correlation coefficient (stability of 
connections between neighboring nodes, similar to clustering coefficient) (22), and temporal 
variation in efficiency and clustering coefficient (55). We also calculated total functional 
connectivity, as it may affect group comparisons of other graph measures (56). See Figure 1 
for examples and Supplemental Methods for definitions. 
 
Statistical analysis 
Changes in clinical measures were analyzed using ANOVAs and t-tests, and Cohen’s d effect 
size was calculated (57). Group differences in graph measures were analyzed using 
permutated Wilcoxon-Mann–Whitney tests in the coin package in R (version 3.5.0), while 
main effects of time, group and group × time interactions were performed using the nparLD 
package (58). NparLD applies a non-parametric rank-based model (58), and p-values were 
calculated using a modified F-statistic that is well suited to small sample sizes (59). Within-
group changes over time were analyzed using Wilcoxon signed-rank tests. P-values for 
Wilcoxon-Mann–Whitney and Wilcoxon signed-rank tests were calculated based on 10,000 
Monte Carlo resamples. Kendall’s tau was used to correlate Y-BOCS, graph measures, and 
changes in these variables over time. We used the false discovery rate (FDR; q<.05) (60) to 
correct for multiple comparisons, and report corrected results except when otherwise 
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specified. P-values of Wilcoxon signed-ranks were not corrected but were only performed 
when time or group × time effects were significant. Partial eta squared (ηp2) was calculated 
for time, group and group × time effects using the modified F-statistic (61), and we calculated 
the r effect size for Wilcoxon-Mann–Whitney and Wilcoxon signed-rank tests (62) (small 
r≥0.10, medium r≥0.30, large r≥0.50) (63). A positive r for Wilcoxon-Mann–Whitney tests 
indicates that the value was greater in OCD patients than healthy controls. For Wilcoxon 
signed-rank tests a positive r indicates an increase over time. As previous studies have shown 
effects of SRIs on limbic, frontal and striatal activation and connectivity (10, 12, 23, 64), we 
investigated graph measures in both the entire OCD sample and in unmedicated patients only. 
We also explored whether comorbid mood and anxiety disorders and age of onset were 
related to changes in graph measures in OCD patients.  
 
Results 
Clinical and demographic characteristics 
Patients and healthy controls were matched on sex, age, handedness and educational 
achievement both before and after treatment (p>.58) (Table 1 and Supplemental Table 3). 
OCD patients scored significantly higher on OCI-R, PHQ-9, and GAD-7 (Table 1). 
 
Treatment effectiveness 
One week after B4DT, OCD patients showed significantly lower severity scores on the Y-
BOCS (t(27)=11.77, d=2.93, p<.01), OCI-R (t(24)=6.66, d=1.28, p<.01), GAD-7 (t(24)=3.74, 
d=0.73, p<.01), but not PHQ-9 (t(24)=1.93, d=0.40, p=.07) compared with baseline. 
Seventeen (61%) OCD patients were in remission, 7 (25%) responded, while only 4 (14%) 
showed no clinically significant change. There were no significant group × time effects 
between unmedicated and medicated OCD patients on any clinical measure. Healthy controls 
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showed no significant changes in OCI-R (t(17)=0.34, p=.74), PHQ-9 (t(18)=0.28, p=.78), or 
GAD-7 (t(18)=0.42, p=.68) scores after one week. 
 
Group differences at baseline  
Movement parameters (relative RMS displacement) were not significantly different between 
OCD patients and healthy controls at baseline (t(60)=-1.52, p=.13) or after one week 
(t(45)=.22, p=.83). There were no significant differences after FDR-correction between the 
groups in static or dynamic measures at baseline. At an uncorrected threshold, OCD patients 
showed less variation in connectivity between the FPN and DMN subnetworks compared to 
healthy controls before treatment (r=-0.26, p=.04), which was no longer significant after 
treatment (r<0.01, p=.99). In addition, unmedicated OCD patients showed more connectivity 
between the FPN and limbic subnetwork compared to healthy controls (r=0.30, p=.03), which 
was no longer significant after treatment (r=-0.15, p=.36). 
 
Longitudinal effects 
At the global level 
Static In the entire sample of OCD patients and healthy controls we found significant effects 
of time for increased global efficiency and average clustering coefficient (ηp2=0.17, p<.01 for 
both). There were no between-group differences in total functional connectivity at baseline 
(r=0.05, p=.69) or after one week (r=-0.08, p=.60), but there was a significant effect of time 
for increased total functional connectivity (ηp2=0.14, p<.01)(See Table 2 for detailed 
information). When medicated OCD patients were excluded from the analyses significant 
group × time effects were found for efficiency, clustering coefficient, and total functional 
connectivity (Table 3). There were no significant effects for modularity. 
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Dynamic In the entire sample of OCD patients and healthy controls we found a significant 
effect of time for the mean temporal correlation coefficient (ηp2=0.19, p<.01), driven by an 
increase in healthy controls (r=0.53, p=.02), while OCD patients showed no significant 
change over time (r=0.1, p=.62). When medicated OCD patients were excluded from the 
analyses significant group × time effects were found for the temporal correlation coefficient. 
There were no significant effects for flexibility or promiscuity. 
 
At the subnetwork level 
Static In the entire sample of OCD patients and healthy controls we found a significant effect 
of time for increased connectivity between the SMN and VAN (ηp2=0.20, p=.01), which was 
not observed when medicated OCD patients were excluded from the analysis. We also found 
a significant group × time effect for connectivity between the FPN and limbic subnetwork 
(ηp2=0.16, p=.03). However, neither OCD patients (r=-0.22, p=.24) nor healthy controls 
(r=0.29, p=.23) showed no significant changes over time in within-group analyses. When 
comparing unmedicated OCD patients to healthy controls we also found the significant group 
× time effect for connectivity between the FPN and limbic subnetwork (ηp2=0.19, p=.03, see 
Figure 2 and Table 3), where unmedicated OCD patients showed significantly reduced FPN-
limbic connectivity over time (r=-0.44, p=.04) while healthy controls showed no significant 
change (r=0.29, p=.23).  
 Significant time effects were also found for increased efficiency in the SMN 
(ηp2=0.11, p=.04) and VA (ηp2=0.12, p=.04) and for increased clustering coefficient in the 
SMN (ηp2=0.18, p=.01), VAN (ηp2=0.16, p=.01), DMN (ηp2=0.12, p=.02) and limbic 
subnetwork (ηp2=0.09, p=.04). When medicated OCD patients were excluded from the 
analyses significant group × time effects were found for SMN, VAN, FPN, limbic and DMN 
clustering as well as limbic efficiency. 
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Dynamic In the entire sample of OCD patients and healthy controls we found a significant 
effect of time for the SMN with increased variation in efficiency (ηp2=0.21, p<.01). When 
medicated OCD patients were excluded from the analyses significant group × time effects 
were found for variation in SMN efficiency and clustering (Table 3).  
 
At the regional level 
Static No significant time or group × time effects were found in the entire sample of OCD 
patients and healthy controls, nor when medicated OCD patients were excluded from the 
analyses. 
Dynamic No significant time or group × time effects were found in the entire sample of OCD 
patients and healthy controls. The analysis in unmedicated OCD patients versus healthy 
controls showed a significant group × time effect for flexibility of the right sgACC (ηp2 
= 0.18, p = .03, see Figure 2 and Table 3), driven by a reduction in OCD patients (r=-.52, 
p=.02) while healthy controls showed no significant change (r=0.37, p=.11). There was also a 
significant effect of time with reduced flexibility in the right dorsolateral putamen 
(ηp2=0.21). There were no significant effects for variation in clustering coefficient, strength, 
flexibility or promiscuity in other regions. 
 
Relation between graph measures and clinical characteristics in OCD patients 
We found no significant correlations between pre-treatment Y-BOCS, and graph measures 
nor between changes in symptom severity and graph measures. Secondary analyses showed 
that the presence of comorbid anxiety disorders and the age at onset of OCD were not 
significantly related to change in FPN-limbic connectivity or sgACC flexibility. Changes in 
right sgACC flexibility in depressed versus non-depressed OCD (measured using the SCID) 
patients showed a significant group × time effect (F(1,19)=6.11, ηp2=0.26, p=.01), which was 
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driven by a larger decrease in depressed (r=-0.89, p=.02) than non-depressed (r=-0.23, p=.41) 
patients. 
  




This is the first study to investigate treatment-induced changes of the functional connectome 
of OCD patients after concentrated ERP, and the first to utilize dynamic graph measures in 
OCD patients. The concentrated treatment format allowed for investigating rapid changes 
after only one week. Analyses of the whole sample, including both medicated and 
unmedicated patients, showed few significant results. After excluding medicated patients, 
however, we found significant reductions in FPN-limbic connectivity and sgACC flexibility 
after treatment in OCD patients. The connectivity between the FPN and limbic subnetwork 
was also higher in unmedicated OCD patients than healthy controls before treatment but only 
at an uncorrected threshold. Our findings suggest that concentrated ERP leads to a direct 
reduction and normalization of frontoparietal-limbic topology and a more stable network state 
in the sgACC after only one week of concentrated ERP.  
Connectivity and flexibility of the FPN has been linked to cognitive control in healthy 
controls (50, 65, 66). OCD patients show altered connectivity within the FPN, between the 
FPN and other subnetwork, and altered FPN activation and fronto-limbic connectivity during 
executive and emotion regulation tasks (16, 32, 67-70). Decreased FPN-limbic connectivity 
after treatment could result from a reduced demand for top-down cognitive control, less 
bottom-up limbic interference, or a combination of both (71, 72). This is consistent with 
current models of CSTC, fronto-limbic and fronto-parietal circuits in OCD (6, 7) and the 
focus on emotion regulation in B4DT. Changes in FPN-limbic functional connectivity may 
also overlap with less effective structural connections between limbic regions (such as the 
amygdala and temporal pole) than healthy controls (73), which deserves further investigation. 
In line with our results, previous studies have also shown that medication use may obscure 
abnormal connectivity and activation in OCD, especially in limbic areas (10, 12, 23). 
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The sgACC is involved in many mental processes, including emotional and 
interoceptive processing through its striatal and thalamic projections and is a major node 
within the affective CSTC circuit (6, 72). OCD patients show greater sgACC activation and 
connectivity with striatal and limbic regions than healthy controls (8-10). The reduction in 
flexibility of sgACC after treatment could therefore represent a shift to a more stable network 
and less effort towards bridging communication between regions involved in obsessive 
thoughts, emotion regulation, and compulsive behaviors. The sgACC has been implicated in 
altered network communication with limbic and DMN subnetworks in depression (74). 
Patients who were depressed before treatment showed larger decreases in sgACC flexibility 
compared to non-depressed patients, which suggests that a more stable network state in this 
region is particularly relevant in OCD patients with depression. 
We expected OCD patients to show less global and subnetwork efficiency and 
clustering coefficient before treatment than healthy controls (and more in the limbic 
subnetwork), normalizing after treatment. However, we found no difference between the 
groups at any time-point while only healthy controls showed a significant increase over time, 
particularly in the SMN. Previous studies have also found increased connection strength 
between visual, frontal, parietal, and posterior cingulate cortices and the rest of the brain in 
healthy controls after 12-14 weeks (21, 25). Similar increases and variation have also been 
found in other studies of healthy controls (75). These may be explained by 1) OCD patients 
showing less normal increases in network integration and clustering over time, 2) controls 
reacting differently to being in the scanner for the second time, or 3) controls showing a 
greater increase in total functional connectivity. Unexpectedly, several of our hypothesized 
baseline differences between OCD patients and healthy controls were not found in the present 
study, which may result from methodological differences between studies and differences in 
clinical characteristics of the included participants. Several unexpected group × time effects 
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were also found for some measures where there was no significant difference between OCD 
patients and healthy controls before or after treatment. These indicate subtle but opposing 
changes in the groups over time. Future comparisons over longer time periods are needed to 
determine the role and stability of these network characteristics over time.  
The present study has some limitations. First, the limited sample size required 
balancing power and controlling sample heterogeneity (such as medication status). Having 
few non-responding patients also limited the correlations between treatment outcome and 
graph measures, and the lack of a comparison condition leaves a small possibility that the 
changes are not specific to psychological treatment. A longer fMRI session may have 
improved the reliability of the static measures and allowed for more windows in the dynamic 
measures (76), but the duration was similar to other relevant studies of OCD (12, 77). We 
were also unable to rule out intermittent sleeping during scanning. Graph measures can be 
influenced by movement during scanning, graph thresholding, preprocessing, and scanning 
duration (26, 27). We therefore applied strict exclusion criteria for movement and applied 
independent component and regression analyses to further correct for movement and 
physiological noise. However, there is currently no consensus on how to process and analyze 
rs-fMRI data, and it is likely that some of the variation in imaging studies are due to 
differences in preprocessing and analyses. More research is also needed to determine the role 
of different clinical characteristics (e.g. medication use, comorbidity, severity) in connectome 
abnormality and plasticity. 
Our results show that concentrated ERP for OCD leads to rapid decreases in FPN-
limbic connectivity and flexibility in the right sgACC in unmedicated OCD patients after only 
a week, suggesting a more independent topology and stable network state after effective 
treatment. In line with previous studies, we found that SRI use was not related to treatment 
outcome but may obscure limbic abnormalities and treatment-related changes over time in 
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limbic regions. Future studies should compare the short-term effects of symptom reduction 
and long-term effects of normalized behavior, in addition accounting for the effects of 
medication use, on the connectome.  
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Figure 1 Levels of network analyses and model of selected graph measures 
Topological model of hypothetical nodes of a brain. Panel A: Illustration of included nodes at the global, 
subnetwork, and regional levels. The rostral PFC was chosen as it is part of the DMN and is easily visible on the 
same axial slice. Panel B: Shows how nodes can be divided into functional modules. Global efficiency measures 
how easily information can cross from one side of the network to the other. Clustering coefficient measures if a 
node’s neighbors are also neighbors of each other and indicates functional segregation. Betweenness centrality 
indicates a nodes importance for efficient network communication. Panel C: Flexibility is how often a node 
switches which module it belongs to. Panel D: Promiscuity is how often a node switches between multiple 
different modules. Panel E: Temporal correlation coefficient is how stable the connections of a node’s neighbors 
are over time.  
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Figure 2 Frontoparietal-limbic connectivity and subgenual ACC flexibility over time 
Panel A: Mean (± standard error) connectivity between the frontoparietal and limbic subnetworks over time 
where unmedicated OCD patients showed more connectivity before treatment relative to healthy controls, which 
normalised after treatment. Healthy controls did not show any significant change over time. Frontal regions of 
the FPN (blue) and frontal and temporal regions of the limbic subnetwork (red) are overlaid on MNI template. 
Panel B: Mean (± standard error) flexibility of the right sgACC over time, where unmedicated OCD patients 
showed a decrease after treatment relative to healthy controls. Healthy controls did not show any significant 
change over time. SgACC (red) is overlaid on MNI template. 
  




Table 1 Demographics and clinical information of sample 
 OCD (n = 34) HC (n = 28) !2 p-value* 
 n (%) n (%)   
Sex   5.37 .60 
Male 14 (41) 9 (32)   
Female 20 (59) 19 (68)   
Handedness   5.89 .58 
Right 33 (97) 26 (93)   
Left 1 (3) 2 (7)   
OCD onset     
Childhood 15 (44) NA   
Adult 19 (56) NA   
Comorbid disorders     
MDD 10 (29) NA   
GAD 11 (32) NA   
SAD 8 (24) NA   
SP 4 (12) NA   
PD±AG 5 (15) NA   
Hypochondriasis 3 (9) NA   
Dysthymia 2 (6) NA   
PTSD 1 (3) NA   
ADHD 1 (3) NA   
Somatization disorder 1 (3) NA   
Pain disorder 1 (3) NA   
 M (SD) M (SD) t p-value 
Age 30.12 (8.84) 30.96 (10.75) 0.34 .74 
Education (years) 14.68 (2.40) 14.43 (2.30) 0.41 .68 
Before treatment     
Y-BOCS 26.68 (3.97) NA   
OCI-R 25.21 (9.72) 6.56 (7.87) 6.45 < .01 
PHQ-9 11.55 (6.30) 2.41 (1.55) 8.39 < .01 
GAD-7 12.79 (5.06) 2.30 (1.90) 10.46 < .01 
Mean RMS .07 (.03) .06 (.02) 1.61 .13 
After one week for 28 OCD and 19 HC 
Y-BOCS 10.96 (6.39) NA   
OCI-R 13.20 (9.33) 5.78 (7.77) 2.75 < .01 
PHQ-9 9.24 (6.55) 2.17 (1.95) 5.10 < .01 
GAD-7 9.16 (5.06) 1.83 (2.09) 6.50 < .01 
Mean RMS .07 (.03) .07 (.02) -.22 .83 
* P-values are not corrected for multiple comparisons. ADHD, Attention-deficit/hyperactivity disorder; AG, 
Agoraphobia; GAD-7, Generalized Anxiety Disorder-7; HC, Healthy controls; MDD, Major depressive disorder; 
NA, Not applicable; OCD, Obsessive-Compulsive Disorder; PHQ-9, Patient Health Questionnaire-9; PD, Panic 
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disorder; PTSD, Post-traumatic stress disorder; RMS, root mean square; SAD, Social anxiety disorder; SP, 
specific phobia; Y-BOCS, Yale-Brown Obsessive-Compulsive Scale.
Functional connectome after B4DT for OCD 
 
29 
Table 2 Significant changes in graph measures over time in entire sample of OCD patients (n=28) and healthy controls (n=19) 
 
Non-parametric ANOVA* Within-group comparisons 
 
Group Time Interaction OCD HC 
 
F ηp2 p F ηp2 p F ηp2 p p r p r 
Global 
Efficiency 0.05 0 .82 9.40 0.17 < .01 2.93 0.06 .09 .76 0.06 .03 0.51 
Clustering coefficient 0.06 0 .81 9.27 0.17 < .01 2.97 0.06 .09 .81 0.05 .03 0.52 
Temporal correlation coefficient 0.06 0 .75 9.27 0.17 .01 2.97 0.06 .32 .62 0.1 .02 0.53 
Total functional connectivity 0.12 0 .73 7.12 0.14 < .01 2.37 0.05 .12 .69 0.08 .06 0.42 
Subnetwork 
FPN-limbic connectivity 1.14 0.03 .99 0.18 0.01 .90 8.67 0.19 .03 0.04 -0.44 0.22 0.29 
SMN-VAN connectivity 0.07 0 .90 9.83 0.18 .02 1.36 0.03 .32 0.33 0.19 0.02 0.53 
SMN-VAN connectivity 0.16 0 .98 11.44 0.2 .01 2.08 0.04 .35 .34 0.19 .01 0.58 
SMN efficiency 0.05 0 .99 5.50 0.11 .05 2.34 0.05 .32 0.42 0.16 0.05 0.44 
SMN efficiency 0.03 0 .94 5.8 0.11 .04 2.88 0.06 .22 .47 0.14 .05 0.44 
VAN efficiency 0.01 0 .99 6.96 0.13 .04 0.54 0.01 .47 0.28 0.21 0.08 0.41 
VAN efficiency 0.01 0 .94 5.96 0.12 .04 0.54 0.01 .46 .36 0.18 .12 0.37 
SMN clustering 0.02 0 .90 9.94 0.18 .01 3.85 0.08 .15 0.64 0.09 0.02 0.55 
SMN clustering 0.02 0 .93 10.01 0.18 .01 4.33 0.09 .15 .58 0.11 .02 0.55 
VAN clustering 0.02 0 .90 9.11 0.17 .01 2.06 0.04 .15 0.66 0.09 0.09 0.40 
VAN clustering 0.01 0 .93 8.71 0.16 .01 2.03 0.04 .15 .59 0.1 .10 0.39 
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DMN clustering 0.04 0 .90 5.32 0.11 .04 2.15 0.05 .15 0.85 0.04 0.03 0.49 
DMN clustering 0.05 0 .93 6.07 0.12 .02 2.19 0.05 .15 .80 0.05 .04 0.46 
Limbic clustering 0.02 0 .90 4.59 0.09 .04 3.47 0.07 .15 0.79 -0.05 0.04 0.46 
Limbic clustering 0.01 0 .93 4.56 0.09 .04 2.49 0.05 .15 .90 -0.03 .05 0.45 
Variation in SMN efficiency 3.16 0.07 .38 13.43 0.23 < .01 1.00 0.02 .67 0.09 0.33 0.02 0.55 
Variation in SMN efficiency 2.36 0.05 .29 11.69 0.21 < .01 1.46 0.03 .59 .14 0.28 .01 0.55 
Regional 
None after FDR correction              
*P-values are corrected for multiple comparisons. DMN, Default mode network; FDR, False discovery rate; FPN, Frontoparietal network; HC, 
Healthy controls; OCD, Obsessive-compulsive disorder; SMN, Somatomotor network; VAN, Ventral attention network.  
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Table 3 Significant changes in graph measures over time in unmedicated OCD patients (n=21) and healthy controls (n=19) 
 
Non-parametric ANOVA* Within-group comparisons 
 
Group Time Interaction OCD HC 
 
F ηp2 p F ηp2 p F ηp2 p p r p r 
Global 
Efficiency 0.30 0.01 .58 5.37 0.12 .02 5.37 0.12 0.02 .54 -0.14 .02 0.51 
Clustering coefficient 0.32 0.01 .57 5.29 0.12 .02 5.29 0.12 0.02 .55 -0.14 .02 0.52 
Temporal correlation coefficient 0 0 .96 4.99 0.12 .07 7.19 0.16 0.04 .52 -0.15 .02 0.53 
Total functional connectivity 0.32 0.01 .57 3.94 0.09 .05 4.52 0.11 0.03 .68 -0.09 .06 0.42 
Subnetwork 
FPN-limbic connectivity 1.14 0.03 .99 0.18 0.01 .90 8.67 0.19 0.03 .04 -0.44 .22 0.29 
FPN-limbic connectivity 1.14 0.03 .99 0.18 0 .90 8.67 0.19 0.03 .04 -0.44 .23 0.29 
SMN clustering 0.20 0.01 .67 6.53 0.15 .05 5.72 0.13 0.04 .76 -0.07 .02 0.55 
SMN clustering 0.20 0.01 .66 6.61 0.15 .05 6.33 0.14 0.03 .92 -0.03 .01 0.55 
VAN clustering 0.23 0.01 .67 4.96 0.12 .07 5.16 0.12 0.04 .73 -0.08 .09 0.40 
VAN clustering 0.20 0.01 .66 4.66 0.11 .08 5.33 0.12 0.03 .78 -0.06 .10 0.39 
FPN clustering 0.37 0.01 .67 1.57 0.04 .21 4.70 0.11 0.04 .43 -0.18 .03 0.49 
FPN clustering 0.44 0.01 .66 1.20 0.03 .27 4.67 0.11 0.03 .49 -0.16 .04 0.46 
DMN clustering 0.18 0.01 .67 2.82 0.07 .16 4.30 0.10 0.04 .48 -0.16 .03 0.49 
DMN clustering 0.19 0 .66 3.38 0.08 .11 4.51 0.11 0.03 .50 -0.16 .05 0.46 
Limbic clustering 0.30 0.01 .67 1.80 0.05 .21 6.33 0.14 0.04 .19 -0.30 .04 0.46 
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Limbic clustering 0.23 0.01 .66 1.76 0.04 .23 4.72 0.11 0.03 .26 -0.25 .05 0.45 
Limbic efficiency 0.13 0 .72 0.14 0.00 .89 6.85 0.15 .04 .07 -0.39 .09 0.40 
Variation in SMN efficiency 2.78 0.07 .48 12.21 0.24 < .01 0.68 0.02 0.51 .10 0.37 .02 0.55 
Variation in SMN efficiency 2.36 0.05 .43 11.69 0.21 < .01 1.46 0.03 0.47 .11 0.35 .01 0.55 
Variation in SMN clustering 1.97 0.05 .57 7.28 0.16 .04 0.22 0.01 .88 .24 0.27 .10 0.38 
Variation in SMN clustering 1.27 0.03 .64 6.48 0.13 .04 0.53 0.01 0.82 .21 0.28 .10 0.38 
Regional 
Flexibility in R sgACC 1.13 0.03 .70 0.14 0 .79 8.53 0.18 0.03 .02 -0.52 .11 0.37 
Flexibility in R dorsolateral putamen 0.00 0 .96 10.08 0.21 .01 0.3 0.01 0.77 .09 -0.37 .04 -0.48 
*P-values are corrected for multiple comparisons. DMN, Default mode network; FPN, Frontoparietal network; HC, Healthy controls; OCD, 
Obsessive-compulsive disorder; R, Right; SgACC, Subgenual anterior cingulate cortex; SMN, Somatomotor network; VAN, Ventral attention 
network 
